Bayat Sahar, Gholami Milad, Khodadadi Hamidreza, Ghazavi Mohammadreza, Nasiri Jafar, Kheirollahi Majid
Department of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Biochemistry and Genetics, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Mol Biol Rep. 2025 Feb 18;52(1):242. doi: 10.1007/s11033-025-10302-y.
Mutations in the KAT6A gene, which encodes a histone acetyltransferase, have been linked to an autosomal dominant neurodevelopmental disorder known as the Arboleda-Tham syndrome. The clinical symptoms of this disorder are nonspecific and pose challenges to accurately characterizing the condition based solely on these symptoms. This study aimed to establish a definitive diagnosis in three patients with intellectual disability and multiple congenital anomalies, and to elucidate the genotype-phenotype correlation based on the existing literature.
In this study, we investigated three probands with severe intellectual disability, global developmental delay, hypotonia, gait disturbance, microcephaly, scoliosis, abnormal heart morphology, strabismus, gastrointestinal dysmotility, and abnormal facial shape, using karyotype analysis, multiplex ligation-dependent probe amplification, and whole exome sequencing. We also conducted a comprehensive literature review of previously reported cases.
The karyotype analysis and Multiplex ligation-dependent probe amplification results were normal. Whole exome sequencing revealed three novel de novo mutations, c.3712G > T (p.Glu1238*), c.3561 C > A (p.Cys1187*), and c.1069 C > T (p.Arg357*), in the KAT6A gene (NM_006766.5). The heterozygous variants were verified by Sanger sequencing and were not present in either parent.
In this study, we describe three cases of de novo KAT6A variants that were identified for the first time in Iran. Our results expand the understanding of the clinical features associated with Arboleda-Tham syndrome and validate the effectiveness of whole-exome sequencing to rapidly and accurately determine the etiology of such disorders. Furthermore, our literature review demonstrated close genotype-phenotype correlations associated with KAT6A and Arboleda-Tham syndrome.
编码组蛋白乙酰转移酶的KAT6A基因突变与一种常染色体显性神经发育障碍有关,即阿博莱达 - 塔姆综合征。该疾病的临床症状不具有特异性,仅基于这些症状准确表征病情具有挑战性。本研究旨在对三名患有智力残疾和多种先天性异常的患者进行明确诊断,并根据现有文献阐明基因型与表型的相关性。
在本研究中,我们使用核型分析、多重连接依赖探针扩增和全外显子组测序,对三名患有严重智力残疾、全面发育迟缓、肌张力减退、步态障碍、小头畸形、脊柱侧弯、心脏形态异常、斜视、胃肠动力障碍和面部形状异常的先证者进行了调查。我们还对先前报道的病例进行了全面的文献综述。
核型分析和多重连接依赖探针扩增结果均正常。全外显子组测序在KAT6A基因(NM_006766.5)中发现了三个新的新生突变,即c.3712G>T(p.Glu1238*)、c.3561C>A(p.Cys1187*)和c.1069C>T(p.Arg357*)。通过桑格测序验证了杂合变异,且在父母双方中均未出现。
在本研究中,我们描述了三例在伊朗首次发现的新生KAT6A变异病例。我们的结果扩展了对与阿博莱达 - 塔姆综合征相关临床特征的认识,并验证了全外显子组测序在快速准确确定此类疾病病因方面的有效性。此外,我们的文献综述表明KAT6A与阿博莱达 - 塔姆综合征之间存在密切的基因型 - 表型相关性。